Texas Bank & Trust’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.05M Buy
3,497
+138
+4% +$163K 1.32% 20
2026
Q2
$4.03M Sell
3,359
-264
-7% -$270K 1.32% 21
2026
Q1
$3.33M Sell
3,623
-619
-15% -$628K 1.25% 20
2025
Q4
$4.56M Sell
4,242
-92
-2% -$88K 1.66% 10
2025
Q3
$3.31M Sell
4,334
-71
-2% -$52.8K 1.25% 20
2025
Q2
$3.43M Sell
4,405
-190
-4% -$148K 1.37% 19
2025
Q1
$3.8M Sell
4,595
-151
-3% -$126K 1.61% 12
2024
Q4
$3.66M Buy
+4,746
New +$3.93M 1.51% 13

Other funds holding LLY

Texas Bank & Trust's LLY Position: Q3 2026 in Review

Texas Bank & Trust increased its Eli Lilly (LLY) stake by 4.1% in Q3 2026, buying an estimated $163K and bringing the position to 3,497 shares worth $4.05M. The position accounts for 1.32% of the portfolio, ranked #20.

Texas Bank & Trust first reported a position in LLY in Q4 2024 and has held it in 8 quarters since. The position peaked at $4.56M in Q4 2025. 4,613 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Texas Bank & Trust held 3,497 shares of Eli Lilly worth $4.05M as of Q3 2026.
  • Texas Bank & Trust bought 138 Eli Lilly shares in Q3 2026, an estimated $163K.
  • Eli Lilly made up 1.32% of Texas Bank & Trust's portfolio in Q3 2026, its #20 holding.
  • Texas Bank & Trust first reported a position in Eli Lilly in Q4 2024 and has held it in 8 quarters since.
  • Texas Bank & Trust's Eli Lilly position peaked at $4.56M in Q4 2025.
  • 4,613 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Texas Bank & Trust's 13F filing for Q3 2026, filed 4 Nov 2026.